Cargando…
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases
With over 60,000 cases diagnosed annually in the US, ductal carcinoma in situ (DCIS) is the most prevalent form of early-stage breast cancer. Because many DCIS cases never progress to invasive ductal carcinomas (IDC), overtreatment remains a significant problem. Up to 20% patients experience disease...
Autores principales: | Acevedo, Diana Sofía, Fang, Wei Bin, Rao, Vinamratha, Penmetcha, Vedha, Leyva, Hannah, Acosta, Gabriela, Cote, Paige, Brodine, Rebecca, Swerdlow, Russell, Tan, Lin, Lorenzi, Philip L, Cheng, Nikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010752/ https://www.ncbi.nlm.nih.gov/pubmed/35405500 http://dx.doi.org/10.1016/j.neo.2022.100791 |
Ejemplares similares
-
Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression
por: Fang, Wei Bin, et al.
Publicado: (2021) -
CCL2, CCR2 Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration
por: Gudauskiene, Gaile, et al.
Publicado: (2022) -
CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020) -
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021) -
Targeting the CCL2-CCR2 axis in depressive disorders
por: Curzytek, Katarzyna, et al.
Publicado: (2021)